X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (2) 2
aged (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
article (2) 2
biomarkers (2) 2
cancer (2) 2
colorectal cancer (2) 2
colorectal carcinomas (2) 2
colorectal neoplasms - genetics (2) 2
disease-free survival (2) 2
dna mismatch repair (2) 2
dna repair (2) 2
female (2) 2
genetic recombination (2) 2
humans (2) 2
immune checkpoint (2) 2
index medicus (2) 2
lymphocytes (2) 2
male (2) 2
microsatellite instability (2) 2
middle aged (2) 2
mismatch repair (2) 2
mutation (2) 2
pancreatic cancer (2) 2
patients (2) 2
pd-1 protein (2) 2
programmed cell death 1 receptor - antagonists & inhibitors (2) 2
survival (2) 2
tumors (2) 2
yeast (2) 2
abridged index medicus (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - secondary (1) 1
aged, 80 and over (1) 1
analysis (1) 1
anti-pd-l1 antibody (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibody diversity (1) 1
antigens (1) 1
antigens, neoplasm - immunology (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
apoptosis (1) 1
autoantigens (1) 1
bioindicators (1) 1
biomarkers, tumor - antagonists & inhibitors (1) 1
body weight (1) 1
brain neoplasms - genetics (1) 1
brain neoplasms - immunology (1) 1
brain neoplasms - mortality (1) 1
brain neoplasms - therapy (1) 1
cancer therapies (1) 1
carcinoma (1) 1
cell cycle checkpoints - drug effects (1) 1
cell lung-cancer (1) 1
checkpoint blockade (1) 1
clinical activity (1) 1
clinical trials (1) 1
colon (1) 1
colon cancer (1) 1
colorectal carcinoma (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - immunology (1) 1
colorectal neoplasms - mortality (1) 1
colorectal neoplasms - pathology (1) 1
colorectal neoplasms - therapy (1) 1
death (1) 1
dna (1) 1
dna sequencing (1) 1
drug dosages (1) 1
epigenetics (1) 1
functional analysis (1) 1
genetic aspects (1) 1
genetic disorders (1) 1
genomes (1) 1
germline mutations (1) 1
health aspects (1) 1
hypotheses (1) 1
immune system (1) 1
immunogenicity (1) 1
immunotherapy (1) 1
kaplan-meier estimate (1) 1
ligands (1) 1
long-term safety (1) 1
lymphocytes t (1) 1
medical research (1) 1
medicine, general & internal (1) 1
melanoma (1) 1
metastases (1) 1
methods (1) 1
multidisciplinary sciences (1) 1
neoantigens (1) 1
neoplasm metastasis - drug therapy (1) 1
neoplasm metastasis - genetics (1) 1
neoplastic syndromes, hereditary - genetics (1) 1
neoplastic syndromes, hereditary - immunology (1) 1
neoplastic syndromes, hereditary - mortality (1) 1
neoplastic syndromes, hereditary - therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 26, pp. 2509 - 2520
Persons with mismatch repair–deficient tumors are more likely than persons with mismatch repair–proficient tumors to benefit from pembrolizumab — which... 
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands
Journal Article
Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Bioindicators | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.